• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

英国伦敦医护人员中 SARS-CoV-2 N 抗体反应的持久性。

Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.

出版信息

Emerg Infect Dis. 2021 Apr;27(4):1155-1158. doi: 10.3201/eid2704.204554. Epub 2021 Mar 18.

DOI:10.3201/eid2704.204554
PMID:33734962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8007325/
Abstract

Prospective serosurveillance of severe acute respiratory syndrome coronavirus 2 in 1,069 healthcare workers in London, UK, demonstrated that nucleocapsid antibody titers were stable and sustained for <12 weeks in 312 seropositive participants. This finding was consistent across demographic and clinical variables and contrasts with reports of short-term antibody waning.

摘要

在英国伦敦的 1069 名医护人员中进行的严重急性呼吸综合征冠状病毒 2 的前瞻性血清监测表明，在 312 名血清阳性者中，核衣壳抗体滴度在 <12 周内保持稳定和持续。这一发现与抗体短期衰减的报告一致，且不受人口统计学和临床变量的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed7/8007325/3deeb5e995d2/20-4554-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed7/8007325/3deeb5e995d2/20-4554-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed7/8007325/3deeb5e995d2/20-4554-F.jpg

相似文献

1
Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.英国伦敦医护人员中 SARS-CoV-2 N 抗体反应的持久性。
Emerg Infect Dis. 2021 Apr;27(4):1155-1158. doi: 10.3201/eid2704.204554. Epub 2021 Mar 18.
2
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study.非重症 COVID-19 患者中持续的 SARS-CoV-2 核衣壳抗体水平：一项基于人群的研究。
Clin Chem Lab Med. 2020 Nov 19;59(2):e49-e51. doi: 10.1515/cclm-2020-1347.
3
Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.比较两种全自动检测 COVID-19 核衣壳 N 蛋白和刺突 S1/S2 蛋白抗体的检测方法。
Diagn Microbiol Infect Dis. 2021 Jan;99(1):115197. doi: 10.1016/j.diagmicrobio.2020.115197. Epub 2020 Aug 29.
4
Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.日本一种新型自动化化学发光抗SARS-CoV-2 IgM和IgG抗体检测系统的验证，该系统可同时检测N蛋白和S蛋白。
PLoS One. 2021 Mar 4;16(3):e0247711. doi: 10.1371/journal.pone.0247711. eCollection 2021.
5
Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.健康工作者接种一剂 SARS-CoV-2 疫苗后，使用六种自动化 SARS-CoV-2 抗体检测试剂的血清学反应。
Diagn Microbiol Infect Dis. 2021 Oct;101(2):115486. doi: 10.1016/j.diagmicrobio.2021.115486. Epub 2021 Jul 10.
6
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征（MIS-C）中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
7
The complexities of SARS-CoV-2 serology.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清学的复杂性。
Lancet Infect Dis. 2020 Dec;20(12):1350-1351. doi: 10.1016/S1473-3099(20)30699-X. Epub 2020 Sep 23.
8
Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark.丹麦大型医护人员队列中 SARS-CoV-2 感染后血清阴性的危险因素。
Microbiol Spectr. 2021 Oct 31;9(2):e0090421. doi: 10.1128/Spectrum.00904-21. Epub 2021 Oct 20.
9
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.SARS-CoV-2 血清阳性率调查估计受到核衣壳抗体下降的影响。
J Infect Dis. 2021 Apr 23;223(8):1334-1338. doi: 10.1093/infdis/jiaa796.
10
Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust.伦敦国民保健署信托机构内医护人员的 SARS-CoV-2 抗体血清阳性率。
Infect Control Hosp Epidemiol. 2021 Feb;42(2):212-214. doi: 10.1017/ice.2020.402. Epub 2020 Aug 4.

引用本文的文献

1
High prevalence of undocumented SARS-CoV-2 infections revealed by analysis of nucleocapsid-specific IgG responses in diagnosed and undiagnosed individuals.通过对确诊和未确诊个体中核衣壳特异性IgG反应的分析揭示了未记录的SARS-CoV-2感染的高流行率。
PLOS Glob Public Health. 2025 Jan 22;5(1):e0003300. doi: 10.1371/journal.pgph.0003300. eCollection 2025.
2
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses, December 2019 to July 2020.2019年12月至2020年7月对美国献血者进行血清学检测以鉴定严重急性呼吸综合征冠状病毒2和其他冠状病毒
Open Forum Infect Dis. 2024 Jun 28;11(7):ofae351. doi: 10.1093/ofid/ofae351. eCollection 2024 Jul.
3

本文引用的文献

1
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.针对 SARS-CoV-2 感染的强大中和抗体可长期存在。
Science. 2020 Dec 4;370(6521):1227-1230. doi: 10.1126/science.abd7728. Epub 2020 Oct 28.
2
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.人类感染 SARS-CoV-2 后三个月内中和抗体反应的纵向观察和下降。
Nat Microbiol. 2020 Dec;5(12):1598-1607. doi: 10.1038/s41564-020-00813-8. Epub 2020 Oct 26.
3
Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset.
Usefulness and Limitations of Anti-S IgG Assay in Detecting Previous SARS-CoV-2 Breakthrough Infection in Fully Vaccinated Healthcare Workers.
抗S IgG检测在检测完全接种疫苗的医护人员既往新冠病毒突破性感染中的应用价值及局限性
Diagnostics (Basel). 2022 Sep 4;12(9):2152. doi: 10.3390/diagnostics12092152.
4
Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community cohort.病毒学确诊的 SARS-CoV-2 感染后的核衣壳和刺突抗体反应：病毒观察社区队列的观察性分析。
Int J Infect Dis. 2022 Oct;123:104-111. doi: 10.1016/j.ijid.2022.07.053. Epub 2022 Aug 18.
5
Evaluation of a Multiplex Bead Assay against Single-Target Assays for Detection of IgG Antibodies to SARS-CoV-2.评估一种用于检测 SARS-CoV-2 IgG 抗体的多重微球检测与单靶标检测的方法。
Microbiol Spectr. 2022 Jun 29;10(3):e0105422. doi: 10.1128/spectrum.01054-22. Epub 2022 Jun 1.
6
Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: example from an Israeli healthcare worker cohort.将严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗S IgG水平作为既往感染的标志物：来自以色列医护人员队列的实例
Int J Infect Dis. 2022 Jul;120:22-24. doi: 10.1016/j.ijid.2022.04.010. Epub 2022 Apr 9.
7
Persistence of Naturally Acquired and Functional SARS-CoV-2 Antibodies in Blood Donors One Year after Infection.感染一年后献血者体内自然获得的功能性SARS-CoV-2抗体的持久性
Viruses. 2022 Mar 18;14(3):637. doi: 10.3390/v14030637.
8
Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City.墨西哥城最大的三级新冠病毒肺炎转诊医院医护人员中新冠病毒2型血清流行病学研究。
PLoS One. 2022 Mar 17;17(3):e0264964. doi: 10.1371/journal.pone.0264964. eCollection 2022.
9
Unconventional Approaches to Direct Detection of Borreliosis and Other Tick Borne Illnesses: A Path Forward.直接检测莱姆病和其他蜱传疾病的非常规方法：前进之路。
J Cell Immunol. 2021;3(3):164-172. doi: 10.33696/immunology.3.094.
10
Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines.在授权疫苗可用之前，美国新冠病毒抗体检测呈反应性的献血者特征。
Transfus Med Rev. 2021 Jul;35(3):1-7. doi: 10.1016/j.tmrv.2021.07.001. Epub 2021 Jul 30.
SARS-CoV-2 RBD 抗体在症状出现后 4 个月内的纵向恢复期血浆样本中的衰减。
Blood. 2020 Nov 26;136(22):2588-2591. doi: 10.1182/blood.2020008367.
4
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.五种 SARS-CoV-2 免疫测定法的性能特征：头对头基准比较。
Lancet Infect Dis. 2020 Dec;20(12):1390-1400. doi: 10.1016/S1473-3099(20)30634-4. Epub 2020 Sep 23.
5
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻度新冠患者体内抗新冠病毒抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1694-1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
6
Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study.医护人员在 COVID-19 疫情爆发后对 SARS-CoV-2 的免疫反应：一项前瞻性纵向研究。
J Clin Virol. 2020 Sep;130:104575. doi: 10.1016/j.jcv.2020.104575. Epub 2020 Aug 6.
7
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.轻度新冠肺炎患者体内抗SARS-CoV-2抗体的快速衰减
N Engl J Med. 2020 Sep 10;383(11):1085-1087. doi: 10.1056/NEJMc2025179. Epub 2020 Jul 21.
8
Kinetics of viral load and antibody response in relation to COVID-19 severity.病毒载量和抗体反应动力学与 COVID-19 严重程度的关系。
J Clin Invest. 2020 Oct 1;130(10):5235-5244. doi: 10.1172/JCI138759.
9
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.体液免疫反应在感染 SARS-CoV-2 后的动态变化和再次感染的可能性。
J Gen Virol. 2020 Aug;101(8):791-797. doi: 10.1099/jgv.0.001439.
10
Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2.评价基于核衣壳蛋白和刺突蛋白的酶联免疫吸附试验检测抗 SARS-CoV-2 抗体。
J Clin Microbiol. 2020 May 26;58(6). doi: 10.1128/JCM.00461-20.